This compares to loss of $0.30 per share a year ago. Pte polarityte inc — stock price and discussion | stocktwits.
Since then, pte shares have decreased by 54.9% and is now trading at $0.4830.
Pte stock forecast zacks. The average baudax bio stock price prediction forecasts a potential downside of n/a from the current bxrx share price of $0.35. Buy or sell obseva sa. Want the latest recommendations from zacks investment research?
Free stock analysis report to read this article on zacks.com click here. A quarter ago, it was expected that this company. This compares to loss of $0.53 per share a year ago.
Click to get this free report polarityte, inc. The reported ($0.09) earnings per share (eps) for the quarter, beating analysts' consensus estimates of ($0.12) by $0.03. 1278 shares of the stock traded hands, compared to its average volume of 667640.
Click to get this free report polarityte, inc. Polarityte inc nasdaq updated dec 4, 2021 12:04 am. The market expects polarityte, inc.
Today, you can download 7 best stocks for the next 30 days. Polarityte has generated ($0.56) earnings per share over the last year ( ($0.56) diluted earnings per share). Polarityte downgraded by zacks investment research on 10/14/2021.
You'll find the obseva sa. Why polarityte (pte) might surprise this earnings season zacks investment research: (pte) came out with a quarterly loss of $0.06 per share versus the zacks consensus estimate of a loss of $0.12.
Share forecasts, stock quote and buy / sell signals below.according to present data obseva sa.'s obsv shares and potentially its market environment have been in a bullish cycle in the last 12 months. This is a 50 percent increase over losses of $ (0.18) per share from the same. Polarityte q3 eps $ (0.09) beats $ (0.12) estimate, sales $1.12m beat $810.00k estimate.
The analysts previously had rating of buy. Earnings scheduled for may 13, 2021 benzinga: Free stock analysis report to read this article on zacks.com click here.
See the full list of stocks to beat earnings. Each analyst's rating is normalized to a standardized rating. In a note to investors, the firm issued a new rating of hold.
Wall street stock market & finance report, prediction for the future: Pte | complete polarityte inc. () stock market info recommendations:
(pte) came out with a quarterly loss of $0.12 per share versus the zacks consensus estimate of a loss of $0.13. (pte) reports q1 loss, tops revenue estimates zacks investment research: Outlook therapeutics stock has undergone multiple analysts rating changes in the recent past.
(pte) came out with a quarterly loss of $0.09 per share versus the zacks consensus estimate of a loss of $0.13. This compares to loss of $0.18 per share a year ago. Want the latest recommendations from zacks investment research?
This quarterly report represents an earnings surprise of 50%. Outlook therapeutics downgraded by zacks investment research on 10/19/2021. Today, you can download 7 best stocks for the next 30 days.
(pte) came out with a quarterly loss of $0.06 per share versus the zacks consensus estimate of a loss of $0.12. Polarityte last issued its quarterly earnings data on november 10th, 2021. In a note to investors, the firm issued a new rating of sell.
(wve) on wednesday reported a loss of $6.2 million in its third quarter. This compares to loss of. Analyst price target for pte i we calculate consensus analyst ratings for stocks using the most recent rating from each wall street analyst that has rated a stock within the last twelve months.
Shares of polarityte traded up $0.01 on wednesday, reaching $0.61. Polarityte (pte) is seeing favorable earnings estimate revision activity and has a positive zacks earnings esp heading into earnings season. Singapore (ap) _ wave life sciences pte.
The analysts previously had rating of hold. Polarityte (nasdaq:pte) reported quarterly losses of $ (0.09) per share which beat the analyst consensus estimate of $ (0.12) by 25 percent.
